Inactive Instrument

ARYA Sciences Acquisition III A

Equities

ARYA

KYG3166W1069

Arya Sciences Acquisition Corp Iii Reports Earnings Results for the Nine Months Ended December 31, 2020

March 26, 2021 at 05:23 pm

ARYA Sciences Acquisition Corp. III announced earnings results for the nine months ended December 31, 2020. For the nine months, the company announced operating loss was USD 576,035. Net loss was USD 523,083.

Latest news about ARYA Sciences Acquisition III A

ARYA Sciences Acquisition Corp III(NasdaqCM:ARYA) dropped from NASDAQ Composite Index	21-06-09	CI
Nautilus Biotechnology, Inc. completed the acquisition of ARYA Sciences Acquisition Corp III in a reverse merger transaction.	21-06-08	CI
Arya Sciences Acquisition Corp Iii Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Arya Sciences Acquisition Corp Iii Reports Earnings Results for the Nine Months Ended December 31, 2020	21-03-26	CI
Close Update: US Stocks End With New Highs on Stimulus Support From Yellen, Continued Vaccine Deployment	21-02-08	MT
Sector Update: Health Care Stocks Sit Out Monday Markets Rise Despite Biotech Gains	21-02-08	MT
Update: Arya Sciences Acquisition III Shares Almost Double After Unveiling Merger Agreement With Nautilus Biotechnology	21-02-08	MT
Sector Update: Health Care Stocks Edging Lower Despite Solid Gains for Biotechs	21-02-08	MT
US Stocks Advance, Oil Jumps After Treasury Secretary Reinforces Backing for Big US Fiscal Stimulus Plans	21-02-08	MT
Midday Report: US Stocks Advance, Oil Jumps After Treasury Secretary Reinforces Backing for Big US Fiscal Stimulus Plans	21-02-08	MT
ARYA Sciences Acquisition III : Nautilus Biotechnology to Combine with Blank-Check Firm Arya Sciences	21-02-08	MT
DJ Industrial : Wall Street Set for Small Gains, Buoyed by Stimulus Progress	21-02-08	MT
Nautilus Biotechnology, Inc. entered into a definitive merger agreement to acquire ARYA Sciences Acquisition Corp III for approximately $1 billion in a reverse merger transaction.	21-02-07	CI
Certain Class B Ordinary Shares of ARYA Sciences Acquisition Corp III are subject to a Lock-Up Agreement Ending on 3-FEB-2021.	21-02-02	CI
ARYA Sciences Acquisition Corp III announced that it has received $4.99 million in funding from Arya Sciences Holdings III	20-08-10	CI
ARYA Sciences Acquisition Corp III(NasdaqCM:ARYA) added to NASDAQ Composite Index	20-08-10	CI
ARYA Sciences Acquisition Corp III has completed an IPO in the amount of $130 million.	20-08-06	CI
ARYA Sciences Acquisition Corp III has filed an IPO in the amount of $125 million.	20-07-21	CI
ARYA Sciences Acquisition Corp III announced that it expects to receive $4.5 million in funding from Arya Sciences Holdings III	20-07-20	CI

Chart ARYA Sciences Acquisition III A

Duration

Period

More charts

Company Profile

ARYA Sciences Acquisition Corp III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus on entities operating in the healthcare industry, particularly the life sciences and medical technology sectors. It has not commenced any operations.

Sector

More about the company